Highlights Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
6,370 ^JPY	+1.56%		+2.97%	+20.44%

Apr. 09	H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	MT
Mar. 29	Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	Apr. 09	MT
Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation	Mar. 29	MT
EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia	Mar. 27	MT
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	Mar. 17	MT
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka	Feb. 26	DJ
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	Feb. 16	MT
Otsuka Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending December 31, 2024	Feb. 16	CI
Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending December 31, 2024	Feb. 16	CI
Otsuka Holdings Co., Ltd. Announces Year-End Dividend for the Year Ended December 31, 2023, Payable on March 29 , 2024; Provides Second Quarter-End Dividend Guidance for the Fiscal Year 2024	Feb. 13	CI
Otsuka Holdings Lowers 2023 Profit Outlook	Feb. 13	MT
Otsuka's drug for Alzheimer's disease agitation fails in late stage study	Feb. 12	RE
Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ended December 31, 2023	Feb. 12	CI
Final dividend	Dec. 27	FA
Ionis Pharmaceuticals Signs Europe Licensing Deal With Otsuka for Donidalorsen in Hereditary Angioedema	Dec. 18	MT
Otsuka Unit Buys New York-Based Provider of Women Health Products	Dec. 05	MT
US FDA approves Medtronic's blood pressure treatment device for use	Nov. 17	RE
Aurinia Pharmaceuticals Partner Otsuka Pharmaceutical Files New Drug Application For Voclosporin in Japan	Nov. 13	MT
US FDA approves Otsuka's blood pressure treatment device for use	Nov. 07	RE
Otsuka Holdings’ Attributable Profit up 45.6% in Nine-Month Period as Revenue Growth More than Offsets Impairment Losses	Nov. 01	MT
Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	23-10-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Highlights

Filters